Infectious Diseases (except HIV/AIDS)
Showing page 391 of 716 pages of list content
-
The impact of BNT162b2 mRNA vaccine on adaptive and innate immune responses
This article's authors -
Characterization of the emerging B.1.621 variant of interest of SARS-CoV-2
This article's authors -
SARS-CoV-2 seroprevalence in Germany - a population based sequential study in five regions
This article's authors -
Comprehensive mapping of neutralizing antibodies against SARS-CoV-2 variants induced by natural infection or vaccination
This article's authors -
Longitudinal Changes in COVID-19 Associated In-Hospital Mortality
This article's authors -
Detection of persistent SARS-CoV-2 IgG antibodies in oral mucosal fluid and upper respiratory tract specimens following COVID-19 mRNA vaccination
This article's authors -
Non-neutralizing secretory IgA and T cells targeting SARS-CoV-2 spike protein are transferred to the breastmilk upon BNT162b2 vaccination
This article's authors -
Relative role of border restrictions, case finding and contact tracing in controlling SARS-CoV-2 in the presence of undetected transmission
This article's authors -
Evaluation of a multi-species SARS-CoV-2 surrogate virus neutralization test
This article's authors -
Characterizing cellular and molecular variabilities of peripheral immune cells in healthy inactivated SARS-CoV-2 vaccine recipients by single-cell RNA sequencing
This article's authors